DSAM Partners (London) Ltd - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DSAM Partners (London) Ltd ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$6,213,000
-0.2%
140,2700.0%1.04%
-9.6%
Q1 2021$6,224,000
-52.7%
140,270
-41.5%
1.15%
-25.0%
Q4 2020$13,145,000
+220.1%
239,703
+33.4%
1.54%
+116.5%
Q3 2020$4,106,000179,6300.71%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders